Huntsman Cancer Institute shines the spotlight on new discoveries and cutting-edge cancer research. This month, researchers found that increasing access...
New research from Memorial Sloan Kettering Cancer Center (MSK) develops a method for analyzing cancer cells that survive treatment for acute myeloid leukemia;...
A top UVA Health cancer expert is highlighting how a new drug could transform how doctors treat a brain tumor that typically strikes younger people. Credit:...
Seattle-area startup NorthStar Care raised $6 million in a seed funding round co-led by well-known author and business coach Tony Robbins and Chicago-based...
When Sernova announced in June that five patients with type 1 diabetes with severe hyperglycemia and a complete inability to produce insulin were able...
Joe Arron and Mark Eisner worked together for about a decade at Genentech, with broad remits but a shared passion for interstitial lung disease. They’d...
The Biden administration is awarding up to $37 million to Thymmune Therapeutics, the Advanced Research Projects Agency for Health (ARPA-H) announced Thursday....
The sex hormone commonly known as estrogen plays an important role in multiple aspects of women’s health and fertility. High levels of estrogen in the...
The FDA has approved a subcutaneous version of Takeda’s ulcerative colitis drug Entyvio, more than three years after rejecting the company’s application...
SAN DIEGO – Skye Bioscience, Inc. (OTCQB: SKYED), a pharmaceutical company developing drugs targeting the endocannabinoid system, initially through modulation...
Amsterdam, September 28, 2023 – A special supplement to the Journal of Alzheimer’s Disease, published by IOS Press, presents insights and new directions...
The FDA on Thursday approved Amicus Therapeutics’ combo therapy for a rare inherited lysosomal disorder called Pompe disease following several regulatory...
Health Canada’s Special Access Program (SAP) has authorized a physician to provide Apex Labs’ psilocybin macrodose drug protocol to patient Kelsi...
September 27, 2023, NEW YORK – A Ludwig Cancer Research study has for the first time exhaustively analyzed immune cells known as neutrophils that reside...
Pharmaceutical drug developer PharmaTher Holdings further advanced its ketamine-based medical product ambitions with a noteworthy announcement today. The...
Dr. Vanessa Bellat, an assistant professor of chemistry in radiology and an affiliate of the Molecular Imaging Innovations Institute (MI3) at Weill Cornell...
Watch: Biden Almost Falls Down Steps On Same Day As Report About Handlers' 'Mission' To Prevent Him Falling Authored by Steve Watson via Summit...
Cardiff Oncology saw its stock rise after it announced positive Phase II data from its PLK1 inhibitor onvansertib in second-line metastatic pancreatic...
BOSTON, MA (September 27, 2023) – Mass General Cancer Center, a founding member of the Mass General Brigham system, has received the largest gift in...
Reston, VA—A new imaging agent, 68Ga-ABY-025, can predict early metabolic response to human epidermal growth factor receptor 2 (HER2)-targeted treatment...
Prediabetes is a condition that precedes type 2 diabetes and increases the risk of heart attack, kidney and eye disease, and several types of cancer. Currently,...
By bringing further quality control testing into the RightSource Stevenage bioscience cluster, the facility is expected to enable more advanced testing...
Health Canada’s Special Access Program (SAP) has authorized a physician to provide Apex Labs’ psilocybin macrodose drug protocol to patient Kelsi...
HOUSTON – (Sept. 27, 2023) Small and precise: These are the ideal characteristics for CRISPR systems, the Nobel-prize winning technology used to edit...
LAB eN2 will be based in Cambridge, MA, part of the Greater Boston region where Novo has anchored—and earlier this year announced plans to expand—its...
Yale University and Transcend Therapeutics, a rapid-acting psychedelic therapies developer, received a three-year collaborative grant from the U.S....
Researchers at the University of California San Francisco have developed an implantable bioreactor that may pave the way for artificial kidneys. Dialysis...
Researchers at the University of Texas at Austin have developed an electroencephalogram (EEG) sensor that is incorporated into a virtual reality headset....
The Advanced Research Projects Agency for Health (ARPA-H) has awarded $45 million to rapidly develop sense-and-respond implant technology that could slash...
The Dales Report is here with another Psychedelic Exclusive podcast. Today, Shadd and Anthony sit down with analyst Elmer Piros to talk about the investment...